www.novartis.com
Open in
urlscan Pro
172.64.151.144
Public Scan
URL:
https://www.novartis.com/about/innovative-medicines
Submission: On May 20 via manual from US — Scanned from DE
Submission: On May 20 via manual from US — Scanned from DE
Form analysis 2 forms found in the DOM
GET /search
<form action="/search" method="get" id="views-exposed-form-global-search-global-search" accept-charset="UTF-8">
<div class="wrap-global-search-result container">
<fieldset class="js-form-item js-form-type-search-api-autocomplete form-type-search-api-autocomplete js-form-item-keyword form-item-keyword form-no-label form-group">
<div>
<input placeholder="Search" data-drupal-selector="edit-keyword" data-search-api-autocomplete-search="global_search" class="form-autocomplete form-text form-control arc-input ui-autocomplete-input"
data-autocomplete-path="/search_api_autocomplete/global_search?display=global_search&&filter=keyword" type="text" id="edit-keyword" name="keyword" value="" size="30" maxlength="128" autocomplete="off">
</div>
</fieldset>
<fieldset class="js-form-item js-form-type-select form-type-select js-form-item-section form-item-section form-group">
<label for="edit-section">section</label>
<div>
<select data-drupal-selector="edit-section" multiple="multiple" name="section[]" id="edit-section" size="5" class="form-select form-control jqmsLoaded ms-list-1" style="display: none;">
<option value="6">Global</option>
<option value="3236">Digital</option>
<option value="3241">ESG</option>
<option value="26">Media Center</option>
<option value="2096">Careers</option>
</select>
<div id="ms-list-1" class="ms-options-wrap"><button type="button"><span>Global Search</span></button>
<div class="ms-options" style="min-height: 200px; max-height: 1180px;">
<ul style="column-count: 1; column-gap: 0px;">
<li data-search-term="global"><label for="ms-opt-1"><input type="checkbox" title="Global" id="ms-opt-1" value="6">Global</label></li>
<li data-search-term="digital"><label for="ms-opt-2"><input type="checkbox" title="Digital" id="ms-opt-2" value="3236">Digital</label></li>
<li data-search-term="esg"><label for="ms-opt-3"><input type="checkbox" title="ESG" id="ms-opt-3" value="3241">ESG</label></li>
<li data-search-term="media center"><label for="ms-opt-4"><input type="checkbox" title="Media Center" id="ms-opt-4" value="26">Media Center</label></li>
<li data-search-term="careers"><label for="ms-opt-5"><input type="checkbox" title="Careers" id="ms-opt-5" value="2096">Careers</label></li>
<li class="section-uncheck-all"><input type="button" onclick="sectionClearAll(); return false;" id="section-uncheck-all" class="uncheck-all" value="Clear All"></li>
</ul>
</div>
</div>
</div>
</fieldset>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-group" id="edit-actions">
<div>
<span class="d-block d-md-none globa_search_icon_mobile"></span><input data-drupal-selector="edit-submit-global-search" type="submit" id="edit-submit-global-search" value="Search"
class="button js-form-submit form-submit btn btn-primary form-control arc-input">
</div>
</div>
</div>
</form>GET /search
<form action="/search" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form form-row">
<fieldset class="js-form-item js-form-type-textfield form-type-textfield js-form-item-keyword form-item-keyword form-no-label form-group">
<div>
<input placeholder="Search" id="edit-keys" data-drupal-selector="edit-keyword" type="text" name="keyword" value="" size="60" maxlength="128" class="form-text form-control arc-input">
</div>
</fieldset>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-group" id="edit-actions">
<div>
<input data-drupal-selector="edit-submit" type="submit" id="edit-submit" value="Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input">
</div>
</div>
</form>Text Content
Skip to main content
* Search
section
GlobalDigitalESGMedia CenterCareers
Global Search
* Global
* Digital
* ESG
* Media Center
* Careers
*
LANGUAGE & COUNTRY SELECTOR FOR DESKTOP
Global | en
CHOOSE LOCATION
* International
* Americas
* Europe
* Middle East & Africa
* Asia Pacific
* Global | en
* Sandoz | en
* Novartis Foundation | en
* Argentina | es
* Brazil | pt
* Canada | en
* Canada | fr
* Central America | es
* Colombia | es
* Latin America | es
* Mexico | es
* United States | en
* Venezuela | es
* Austria | de
* Belgium | fr
* Belgium | nl
* Bulgaria | bg
* Czech Republic | cs
* Czech Republic | en
* Denmark | da
* Estonia | et
* Finland | fi
* France | fr
* Germany | de
* Greece | el
* Hungary | hu
* Ireland | en
* Italy | it
* Latvia | lv
* Lithuania | lt
* Netherlands | nl
* Norway | no
* Poland | pl
* Portugal | pt
* Romania | ro
* Russia | ru
* Serbia | sr
* Slovakia | sk
* Spain | es
* Sweden | sv
* Switzerland | de
* Switzerland | fr
* United Kingdom | en
* Egypt | en
* Israel | he
* South Africa | en
* Turkey | tr
* Australia | en
* Bangladesh | en
* Hong Kong S.A.R. | zh
* India | en
* Indonesia | en
* Japan | ja
* Korea | ko
* Mainland China | zh
* Malaysia | en
* Pakistan | en
* Philippines | en
* Singapore | en
* Taiwan | zh
LANGUAGE & COUNTRY SELECTOR FOR MOBILE
Global
CHOOSE LOCATION
International
International Americas Europe Middle East & Africa Asia Pacific
* Argentina | es
* Australia | en
* Austria | de
* Bangladesh | en
* Belgium | fr
* Belgium | nl
* Brazil | pt
* Bulgaria | bg
* Canada | en
* Canada | fr
* Central America | es
* Colombia | es
* Czech Republic | cs
* Czech Republic | en
* Denmark | da
* Egypt | en
* Estonia | et
* Finland | fi
* France | fr
* Germany | de
* Greece | el
* Hong Kong S.A.R. | zh
* Hungary | hu
* India | en
* Indonesia | en
* Ireland | en
* Israel | he
* Italy | it
* Japan | ja
* Korea | ko
* Latin America | es
* Latvia | lv
* Lithuania | lt
* Mainland China | zh
* Malaysia | en
* Mexico | es
* Netherlands | nl
* Norway | no
* Global | en
* Sandoz | en
* Novartis Foundation | en
* Pakistan | en
* Philippines | en
* Poland | pl
* Portugal | pt
* Romania | ro
* Russia | ru
* Serbia | sr
* Singapore | en
* Slovakia | sk
* South Africa | en
* Spain | es
* Sweden | sv
* Switzerland | de
* Switzerland | fr
* Taiwan | zh
* Turkey | tr
* United Kingdom | en
* United States | en
* Venezuela | es
* Menu
* About
* Board of Directors
* Joerg Reinhardt
* Simon Moroney
* Nancy Andrews
* Ton Buechner
* Patrice Bula
* Elizabeth Doherty
* Ana de Pro Gonzalo
* Bridgette Heller
* Daniel Hochstrasser
* Frans van Houten
* Andreas von Planta
* Charles Sawyers
* William Winters
* Charlotte Pamer-Wieser
* Executive Committee
* Vasant Narasimhan
* Shreeram Aradhye, M.D.
* James Bradner
* Victor Bulto
* Karen Hale
* Harry Kirsch
* Rob Kowalski
* Steffen Lang
* Klaus Moosmayer
* Richard Saynor
* Marie-France Tschudin
* Lutz Hegemann
* Michael Willi
* Kees Roks
* Strategy
* People and Culture
* Data and Digital
* Products
* Innovative Medicines
* Sandoz
* Operations
* Global Biotech Cooperations
* Diversity & Inclusion
* Equity
* Diversity & Inclusion Governance and Community
* Inclusivity
* Parental Leave
* Society
* Quality
* Audit program
* Novartis Quality Management System (QMS)
* Product and patient safety training
* Regulatory inspections
* Product recalls
* Third-party suppliers
About Novartis
* Patients and Caregivers
* Novartis Commitment to Patients and Caregivers
* Diseases
* Patient Organization Funding
* Adverse Event Reporting
* COVID-19: Patients and Caregivers
* Stories: Patients Perspectives
Patients & Caregivers
* Healthcare Professionals
* Medical Congresses and Events
* Abstract summaries for EULAR
* Abstract summaries for ACR
* Abstract summaries for EADV
* Products
* Novartis Pipeline
* Managed Access Programs
* Novartis Gene Therapies Managed Access Program
* Novartis External Funding
* Healthcare Professional Resources by Country
* Investigator-Initiated Trials / Studies
* Transparency and Disclosure
Healthcare Professionals
* Research & Development
* Novartis Institutes for BioMedical Research
* Collaborations
* NIBR Global Scholars Program
* Technology Platforms
* Radioligand Therapy
* Gene Therapy
* Cell Therapy
* Research Disease Areas
* Immuno-oncology research at Novartis
* Oncology research at Novartis
* Cardiovascular and metabolic disease research at Novartis
* Autoimmunity, transplantation and inflammatory disease research at
Novartis
* Ophthalmology research at Novartis
* Neuroscience Research at Novartis
* Musculoskeletal Disease Research at Novartis
* DAx: exploratory disease research at Novartis
* Research Locations
* Novartis Institute for Tropical Diseases
* Novartis Pipeline
* Translational Medicine
* Research & Development Approach
* Stories from our Labs
* Open Source Science
Research & Development
* ESG
* Access
* Creating sustainable business models
* Value-Based Pricing
* Sub-Saharan Africa
* Donations
* Novartis Access Principles
* Novartis Oncology Access
* Patents and Licensing
* Ethics, Risk and Compliance
* Ethical Behavior
* Compliance
* Human Rights
* Learning and Engagement
* Risk management
* Environmental Sustainability
* Climate
* Waste
* Water
* Global Health
* Anti-Microbial Resistance (AMR)
* Avoidable Blindness
* Chagas Disease
* Leprosy
* Malaria
* Sickle Cell Disease (SCD)
* Novartis Foundation
* Diversity & Inclusion
* Reporting
* Environmental, Social and Governance (ESG) Index
* ESG Rating Performance
* Codes, Policies and Guidelines
* Materiality Assessment
* Transparency and Disclosure
* Targets
* Positions
Environmental, Social and Governance
* Investors
* Event Calendar
* Financial Data
* Novartis Annual Results
* Novartis Quarterly Results
* Novartis SEC Filings
* Product Sales
* Fixed-Income Securities
* Expected Currency Impact
* Share Data & Analysis
* Share Monitor
* Dividend Information
* Share Ownership
* Share Overview
* Shareholder Information
* General Meetings
* American Depository Receipts (ADR)
* Share Buy-Back
* Frequently Asked Questions
* Company Overview
* Corporate Governance
* Novartis Annual Reporting Suite
* Reporting Archive
* Publications Order Form
* ESG
Investors
* News
* News Archive
* Media Library
* Stories
* Subscribe
News
* Careers
* Career Search
* Our Teams
* Careers in Commercial
* Careers in Communications and Advocacy
* Careers in Consulting
* Careers in Digital
* Careers in Health, Safety & Environment
* Careers in Information Technology (IT)
* Careers in Medical & Development
* Careers in People & Organization
* Careers in Procurement
* Careers in Research
* Careers in Strategy
* Careers in Manufacturing and Supply
* Ethics, Risk & Compliance (ERC)
* Careers in Legal
* Career Programs
* Community Exploration & Learning Lab (CELL)
* Early Talent
* Postdoc Program
* Andreas Bender, PhD
* Boxun Lu, PhD
* The Novartis Innovation Postdoctoral Fellowship
* The Novartis Discovery Postdoctoral Fellowship
* Postdoc Research Themes
* Recognition
* Postdoc Program Leadership
* International Careers
* Learning and Development
* Well-being
* Internship Programs
Careers
* COVID-19 Information Center
COVID-19 Novartis response
* Clinical Trials
Clinical Trials
* Partnering
Partnering
* Contacts
Contacts
Home
Header
INNOVATIVE MEDICINES
Previous Next
1. Home
2. About
3. Innovative Medicines
Our Innovative Medicines business is made up of two separate commercial
organizations, Innovative Medicines International and Innovative Medicines US.
--------------------------------------------------------------------------------
CORE THERAPEUTIC AREAS
* CARDIOVASCULAR
Cardiovascular disease is a global health crisis. Billions of people are
affected physically, emotionally and financially. Thanks to a combination of
our legacy, global footprint and leading science, Novartis is uniquely
positioned to help change this landscape. Our efforts include use of early
interventions and development of pioneering treatments, from prevention to
management, as well as the creation of innovative access models. Our goal is
to reduce and ultimately stop premature death and disability from
cardiovascular disease.
* HEMATOLOGY
Novartis is deeply committed to transforming the lives of people living with
blood cancers and life-threatening blood disorders. Together with its
research partners – Novartis led the era of targeted therapies in cancer and,
in investigating how these medicines could transform patient outcomes.
* SOLID TUMORS
* IMMUNOLOGY
Novartis aims to improve outcomes and enhance the lives of those affected by
painful and debilitating immunological conditions. As a result, we have
already helped transform the standard of care for children and adults
suffering from conditions such as psoriatic disease and axial
spondyloarthritis, chronic urticaria, and a number of rare autoinflammatory
diseases. We continue to focus on discovering and delivering innovative
medicines for complex, less-explored immunological diseases where there is
significant unmet need, such as hidradenitis suppurativa and Sjögren’s
syndrome, lupus and osteoarthritis.
* NEUROSCIENCE
Novartis has been tackling neurological conditions for more than 80 years.
Above all, partnering with patients, healthcare professionals and healthcare
systems to deliver life-changing solutions and treatments is at the core of
what we do. Together, we can innovate to reimagine neuroscience and improve
people’s lives.
--------------------------------------------------------------------------------
OPHTHALMOLOGY
Novartis is reimagining the treatment and prevention of visual impairment and
blindness. We aim to develop life-changing pharmaceuticals and transformative
technologies for diseases and conditions from front to back of the eye.
RESPIRATORY
At Novartis, our focus is on improving the lives of the hundreds of millions of
people living with respiratory diseases, including chronic obstructive pulmonary
disease (COPD) and severe allergic asthma.
--------------------------------------------------------------------------------
NOVARTIS GLOBAL PRODUCT PORTFOLIO AND CLINICAL PIPELINE
155
COUNTRIES IN WHICH PRODUCTS ARE AVAILABLE
See Our Medicines
30
NEW MOLECULAR ENTITIES IN OUR GLOBAL CLINICAL PIPELINE
Explore Our Pipeline
--------------------------------------------------------------------------------
UNDERSTANDING HIDRADENITIS SUPPURATIVA THROUGH JASMINE’S EYES
Jasmine, an HS advocate, journalist and filmmaker, is one of the estimated 1 in
100 of the global population who lives with this debilitating skin disease. HS
has affected every aspect of her life since she was a child.
Read More
SOLVING THE PUZZLE OF IMMUNOTHERAPY
The question of how to unlock the potential of the body’s own immune system to
kill cancer cells is more than a century old. At Novartis, we are building on
insight to unlock the potential of immunotherapies for more patients around the
world.
Read More
ONCOLOGY MEDICAL MEETINGS
Explore Our Hub
Previous Next
NOVARTIS GENE THERAPIES
Novartis Gene Therapies is dedicated to developing and commercializing gene
therapies for patients and families devastated by rare and life-threatening
neurological genetic diseases.
Learn More
--------------------------------------------------------------------------------
INNOVATIVE MEDICINES LEADERSHIP
President, Innovative Medicines International and Chief Commercial Officer
Marie-France Tschudin
Read Biography
President, Innovative Medicines US
Victor Bulto
Read Biography
--------------------------------------------------------------------------------
JOBS IN INNOVATIVE MEDICINES
（高级）医药代表 /（资深）产品专员
Sales, China, PHARMA
实习医药代表
China, PHARMA
（高级）医药代表 /（资深）产品专员
Sales, China, PHARMA
Field Based Brand Manager
Marketing, Cyprus, PHARMA
All Innovative Medicines Jobs
NOVARTIS
NAVIGATE
* Patients and Caregivers
* Healthcare Professionals
* Researchers
* Job Seekers
* Journalists
* Investors
* Partners
* Suppliers
TOPICS
* Clinical Trials
* COVID-19 Info Center
* ESG
EXPLORE
* Stories
* Diseases
* Locations
* Products
* Novartis Pipeline
NOVARTIS COMPANIES
* Sandoz
* Advanced Accelerator Applications
* Gyroscope Therapeutics
*
*
*
*
*
FOOTER BOTTOM
© 2022 Novartis AG
* Terms of Use
* Privacy
* Contacts
* Cookie Settings
* Site Map
* Web Accessibility
* Open Source
Novartis Site Directory
This site is intended for a global audience
YOUR PRIVACY IS IMPORTANT FOR US.
We use cookies to enhance your experience when visiting our websites:
performance cookies show us how you use this website, functional cookies
remember your preferences and targeting cookies help us to share content
relevant to you. Select “Accept all” for giving your consent to all cookies,
select “Cookie settings” for managing the different cookies or select “Reject
all” for using only strictly necessary cookies. You can change your cookie
settings at any point of time by pressing the cookie settings link on the
website.
Cookie Settings Reject all Accept all
COOKIE PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your browser
by using cookies. The cookies are set to expire when the information is no
longer needed or after a maximum period of 13 months. You can choose to allow or
not to allow some specific types of cookies. Click on the different category
headings below to find out more. Please note that blocking some types of cookies
may impact your experience on the site and the services we are able to offer.
Accept all
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
Cookies Details
PERFORMANCE COOKIES
Performance cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
Cookies Details
FUNCTIONAL COOKIES
Functional cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
Cookies Details
TARGETING COOKIES
Targeting cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
Cookies Details
Back Button
BACK
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
*
View Cookies
* Name
cookie name
Save choices